Ucla General Clinical Research entered the industry of Biological Research in 1998 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417115, which describes it as a Biological Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biological Research. The business provides service to the B2B market.
To acquire more information, please contact Isidro Salusky, Executive Director by calling (310) 825-5225 during business hours. You can also write to the business’ Branch at 10833 Le Conte Avenue # 27-066, Los Angeles, California CA 90095. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Ucla General Clinical Research |
| Representative: | Isidro Salusky, Executive Director |
| Place of Business: | 10833 Le Conte Avenue # 27-066, Los Angeles, CA 90095 |
| Contact Number: | (310) 825-5225 |
| Type of Service: | Biological Research |
| SIC Number: | 8731 |
| NAICS Number: | 5417115 |
| Locality: | Branch |
| Market Type: | B2B (Business to Business) |
| Began: | 1998 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Ucla General Clinical Research is a company operating from Los Angeles, California providing professional Biological Research and relevant B2B variables. It was founded in 1998 and registered with the SIC code 8731 as Biological Research, and with the NAICS code 5417115 as Biological Research.
With a current employee count of 1 to 4, Ucla General Clinical Research has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Isidro Salusky, Executive Director at (310) 825-5225 for related queries, or to locate its Branch using the coordinates 34.07019,-118.45102.
The Branch can also be found at the street address 10833 Le Conte Avenue # 27-066 in Los Angeles, California 90095 and can be engaged online through the company website at , the company Twitter , and Facebook page .